4702

Actos Alone or Combined With Oral Meds Improves Your Patient’s BGs and Lipids

New Zealand researchers say that in clinical trials of people with type 2 diabetes, Actos as stand-alone therapy or in combination with metformin, repaglinide, insulin or a sulphonylurea induced “both long- and short-term improvements in [blood glucose] control and serum lipid profiles.”

Actos was also effective in reducing some measures of cardiovascular risk and arteriosclerosis.

Drugs, 2006; 66(1):85-109

Leave a Reply

Your email address will not be published. Required fields are marked *


Time limit is exhausted. Please reload CAPTCHA.